Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate ...
The inflammatory bowel disease therapy succeeded in its first major testing, setting up a competition with several large drugmakers.
New York City-based Weill Cornell Medicine researchers identified a mechanism that may help suppress chronic intestinal inflammation, according to an April 24 study published in the Journal of ...
The number of young Americans with inflammatory bowel disease has been rising for years, leaving the U.S. with one of the highest prevalence rates in the world, a new study finds. More than 100,000 ...
For women with inflammatory bowel disease (IBD), pregnancy is already high-stakes -- and conflicting medical advice worldwide has only added to the uncertainty. Now, a global team of specialists and ...
Inflammatory bowel disease (IBD), is a generalized term for diseases that involve irritation in the colon and rectum. It includes autoimmune diseases like ulcerative colitis and Crohn disease.
For the estimated 5 million people worldwide living with inflammatory bowel disease, finding relief from debilitating symptoms often feels like an endless journey through medication trials and ...
A study in Cellular and Molecular Gastroenterology and Hepatology found that some healthy relatives of patients with inflammatory bowel disease have microbial and metabolomics compositions associated ...
Piper Sandler analyst David Amsellem reiterated the Overweight rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a price forecast of $30. Amsellem writes that he hosted a call with a ...
Inflammatory bowel disease (IBD) flares can be unpredictable, but avoiding common triggers like stress, poor sleep, smoking, and certain dietary factors may help lower your risk of future flare-ups.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results